Open an account

eXoZymes

EXOZ · NASDAQ

$4.12+$0.12 (+3.00%)TodayMarket closed ·
Prev close $4.00

About EXOZ

eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 32 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.

Employees
32
Headquarters
Monrovia California, California
Listed
Nov 13, 2024
Sector
Health Care
Industry
Biotechnology
Website
exozymes.com

EXOZ key statistics

Market cap
38.24M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
9.82K
Volume
4.31K
Open price
$3.97
High today
$4.44
Low today
$4.03
52 Week high
$18.40
52 Week low
$3.71

eXoZymes (EXOZ) at a glance

As of Oct 20, 2026, eXoZymes (EXOZ) shares are priced at $4.12, giving the company a market cap of 38.24M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $4.03 and $4.44. The current price is 2.2% above the day's low and 7.1% below its high.

Volume so far is 4.31K shares, below the average of 9.82K shares a day.

Over the past year eXoZymes has ranged from $3.71 to $18.40, and now sits 3% of the way up that range.

EXOZ news

  • 12 Health Care Stocks Moving In Friday's Intraday Session

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

Similar companies

Companies in the same industry as eXoZymes

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.